|
|
|
STAT3α是子宫内膜癌细胞的致癌因子并介导了自分泌人类生长激素的致癌效应 |
|
|
|
|
|
STAT3α is oncogenic for endometrial carcinoma cells and mediates the oncogenic effects of autocrine human growth hormone |
|
|
|
|
|
Tang J-Z, Kong X-J, Banerjee A, Muniraj N, Pandey V, Steiner M, Perry JK, Zhu T, Liu D-X, Lobie PE 2010/9/26 10:31:00 |
|
【发表评论】
|
|
|
|
打印|
推荐给好友
|
|
|
Endocrinology, 2010, Volume 151, Issue 9
|
|
|
|
|
|
|
We herein demonstrate an oncogenic role for signal transducer and activator of transcription (STAT)-3α (the full length STAT3 isoform), which also mediates autocrine human GH (hGH)-stimulated oncogenicity, in human endometrial carcinoma (EC) cells. Autocrine hGH stimulated Y705 phosphorylation of STAT3 and STAT3-mediated transcriptional activity in a SRC and Janus-2 Kinase dependent manner in human EC cell lines. Forced expression of a constitutively active variant of STAT3α increased proliferation, anchorage-independent, three-dimensional (3D) Matrigel, and xenograft growth and promoted epithelial-mesenchymal transition, migration, and invasion of EC cells. Conversely, the oncogenic capacity of EC cells was significantly impaired by treatment with JSI-124, an inhibitor of STAT3 phosphorylation and activity, small interfering RNA-mediated depletion of STAT3α, or a dominant-negative variant of STAT3α. Furthermore, the enhanced EC cell oncogenicity stimulated by autocrine hGH, was also abrogated by functional inhibition or small interfering RNA-mediated depletion of STAT3α. STAT3α may therefore be a common mediator of oncogenic signaling pathways stimulating progression of EC. Copyright © 2010 by The Endocrine Society
|
|
|
|
|
|
|
Correspondence Address: Lobie, P. E.; Cancer Science Institute of Singapore, National University of Singapore, Centre for Life Sciences, #02-07, 28 Medical Drive, Singapore 117456, Singapore; email:csipel@nus.edu.sg |
|
|
|
|
|
|
|
|
|
|
请登录后发表评论,点击此处登录。
|
|
|
疾病资源中心
王燕燕 王曙
上海交通大学附属瑞金医院内分泌科
患者,女,69岁。2009年1月无明显诱因下出现乏力,当时程度较轻,未予以重视。2009年3月患者乏力症状加重,尿色逐渐加深,大便习惯改变,颜色变淡。4月18日入我院感染科治疗,诉轻度头晕、心慌,体重减轻10kg。无肝区疼痛,无发热,无腹痛、腹泻、腹胀、里急后重,无恶性、呕吐等。入院半月前于外院就诊,查肝功能:ALT 601IU/L,AST 785IU/L,TBIL 97.7umol/L,白蛋白 41g/L,甲状腺功能:游离T3 30.6pmol/L,游离T4 51.9pmol/L,心电图示快速房颤。
医学数据库
|